CytomX Therapeutics, Inc. upgraded to speculative Buy on Varseta-M mCRC data. Click for this updated look at CTMX stock and see why I am now bullish.
Shell (SHEL) looks undervalued with 12% upside to a $100 target. SHEL maintains sector-leading FCF yield, 8.52%. See more ...
Earnings call BKW AG reported CHF 4.5 billion in operating income for 2025, down 4.8% YoY, with EBIT at CHF 113.7 million (-14.6%) and net profit declining 19.3%. Despite lower hydro output and market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results